Radiopharmaceuticals Market is expected to generate a revenue of USD 11.93 Billion by 2030, Globally, at 11.76% CAGR: Verified Market Research®

The market report is a good combination of qualitative and quantitative data that highlights significant market changes, obstacles that business and the competition must overcome, as well as new possibilities and trends in the global Radiopharmaceuticals Market.

JERSEY CITY, N.J. , Jan. 12, 2023 /PRNewswire/ -- Verified Market Research® recently published a report, "Radiopharmaceuticals Market" By Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), By Application (Oncology, Cardiology, Neurology), and By Geography.

As per the deep research carried out by Verified Market Research®, the global Radiopharmaceuticals Market size was valued at USD 4.38 Billion in 2021 and is projected to reach USD 11.93 Billion by 2030, growing at a CAGR of 11.76% from 2023 to 2030.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=26023

Browse in-depth TOC on "Radiopharmaceuticals Market"

202 - Pages
126 – Tables
37 – Figures

Global Radiopharmaceuticals Market Overview

Radiopharmaceuticals are also named nuclear medications as they use radio-active isotopes to treat disorders. Along with the treatment, radiopharmaceuticals are also used for diagnosing many disorders including cancer. Radiopharmaceuticals are extremely useful in various medical fields such as neurology, cardiology, oncology, and others. In cancer, radiopharmaceuticals emit radiation that targets the cancerous tumor cells and kills them, thus curing cancer. Radiopharmaceuticals used for diagnosis purposes are named tracers. Tracers have lower radiation power than radiopharmaceuticals used for treatment purposes.

Timely diagnosis of disorders allows better management and treatment of chronic disorders such as cancer, offering better treatment outcomes. Because of this, the demand for radiopharmaceuticals is increasing as they are used for diagnosis as well as treatment. The technological advancements in nuclear imaging have largely contributed to increasing the demand for nuclear imaging technologies in the medical industry. During the forecast period, this is estimated to be a significant factor in contributing to the market growth.  The prevalence of chronic diseases such as cancer is increasing rapidly, which is significantly expected to increase the demand for radiopharmaceuticals in the coming future.

Verified Market Research® narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The "Global Radiopharmaceuticals Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Key Players

The "Global Radiopharmaceuticals Market" study report will provide valuable insight with an emphasis on the global market.  The major players in the market are Cardinal Health, Inc., Mallinckrodt PLC, GE Healthcare (A Fully-Owned Subsidiary of General Electric Company), Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.P.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc. (A Subsidiary of Sterigenics International LLC.), Advanced Accelerator Applications S.A., Iba Molecular.

Based on the research, Verified Market Research® has segmented the global Radiopharmaceuticals Market into Procedural Volume, Application, and Geography.

• Radiopharmaceuticals Market, by Procedural Volume
• Diagnostic Procedures
• Therapeutic Procedures
• Radiopharmaceuticals Market, by Application
• Oncology
• Cardiology
• Neurology
• Endocrinology
• Other
• Radiopharmaceuticals Market, by Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

Contrast Media Market By Type (Microbubble Contrast Media, Iodinated Contrast Media), By Application (Radiology, Interventional Cardiology), By Modality (Ultrasound, Magnetic Resonance Imaging (MRI)), By Route of Administration (Oral, Rectal), By Indication (Cardiovascular Disorders, Cancer), By Geography, And Forecast

Radiology Services Market By Type (Stationary Digital Radiology Systems and Portable Digital Radiology Systems), By End-User (Hospitals, Diagnostic Centers), By Application (Neurology, Orthopedics, Cardiology), By Geography, And Forecast

Radiotherapy Market By Type (Internal Beam Radiotherapy, External Beam Radiotherapy), By Application (Internal Beam Radiotherapy/Brachytherapy, External Beam Radiation Therapy), By End-User (Hospitals, Independent Radiotherapy Centers), By Geography, And Forecast

Teleradiology Market By Imaging Technique (X-rays, Computed Tomography (CT)), By Technology (Hardware, Software), By End User (Hospitals Ambulatory, Surgical Centers), By Geography, And Forecast

World's Top 10 Pharmaceutical Companies building immunity using affordable drugs

Visualize Radiopharmaceuticals Market using Verified Market Intelligence:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Email: [email protected]
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/1315349/Verified_Market_Research_Logo.jpg

SOURCE Verified Market Research